Technology News and Research

RSS
Specially designed lipid nanoparticles overcome resistance to anti-tumor immunotherapy

Specially designed lipid nanoparticles overcome resistance to anti-tumor immunotherapy

Cross-species locomotion features shared by dopamine-deficient worms, mice, and humans

Cross-species locomotion features shared by dopamine-deficient worms, mice, and humans

AI can help with the diagnosis of B-cell lymphomas and related leukemias

AI can help with the diagnosis of B-cell lymphomas and related leukemias

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

$90 million approved for first-of-its-kind translational research building for mental health

$90 million approved for first-of-its-kind translational research building for mental health

Health Secretary gives blood sample for new genomic sequencing program

Health Secretary gives blood sample for new genomic sequencing program

Scientists identify new approach to overcome resistance to cancer immunotherapy

Scientists identify new approach to overcome resistance to cancer immunotherapy

Owlstone Medical appoints Mark Capone to board of directors

Owlstone Medical appoints Mark Capone to board of directors

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

Researchers take major step forward in the development of microbial fuel cells

Researchers take major step forward in the development of microbial fuel cells

OSU-led collaboration proposes broadening of university promotion, tenure criteria and innovation

OSU-led collaboration proposes broadening of university promotion, tenure criteria and innovation

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

New imaging technique can change the landscape of prostate cancer detection and treatment

New imaging technique can change the landscape of prostate cancer detection and treatment

New NIH-funded research to solve the male infertility and spermatogenesis puzzle

New NIH-funded research to solve the male infertility and spermatogenesis puzzle

Multi-million government fund given to 21 projects to propel innovation across the UK

Multi-million government fund given to 21 projects to propel innovation across the UK

Experts raise questions about routine use of surrogate endpoints for drug approvals

Experts raise questions about routine use of surrogate endpoints for drug approvals

Researchers aim to develop edible plant-based mRNA vaccines

Researchers aim to develop edible plant-based mRNA vaccines

Australian study finds enablers and barriers to COVID-19 vaccine uptake

Australian study finds enablers and barriers to COVID-19 vaccine uptake

Rockefeller saliva test turns out to be easier and safer to administer than conventional COVID tests

Rockefeller saliva test turns out to be easier and safer to administer than conventional COVID tests

Beckman Coulter Life Sciences debuts the future of simplified PCR cleanup and plasmid prep with the EMnetik system

Beckman Coulter Life Sciences debuts the future of simplified PCR cleanup and plasmid prep with the EMnetik system

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.